Shopping Cart
Remove All
Your shopping cart is currently empty
GLP-1(32-36)amide is a pentapeptide compound derived from the C terminus of the glucoregulatory hormone GLP-1. This compound has shown potential in inhibiting weight gain and regulating glucose metabolism in diabetic mice[1][2].


| Description | GLP-1(32-36)amide is a pentapeptide compound derived from the C terminus of the glucoregulatory hormone GLP-1. This compound has shown potential in inhibiting weight gain and regulating glucose metabolism in diabetic mice[1][2]. |
| In vitro | GLP-1(32-36)amide (0.1-10 μM; 24 h) maintains cell viability and reduces apoptosis in INS‐1 cells treated with Streptozotocin (STZ; 1 μM) [2]. |
| In vivo | GLP-1(32-36)amide (1 μmol/kg; i.p. once daily for 21 days) protects islets from damage, inhibits weight gain, and alleviates polydipsia symptoms in diabetic mice[2]. A single dose of GLP-1(32-36)amide (1 μmol/kg; i.p.) slightly reduces mean glucose levels 30 minutes post-glucose challenge in normal mice[2]. GLP-1(32-36)amide (50-70 nmol/kg/d; infusion for 12-16 weeks) prevents diet-induced obesity and hepatic steatosis in high-fat-fed mice[3]. Animal Model: Male KM mice (6-8 weeks; 18-22 g) injected with STZ[2]. |
| Molecular Weight | 570.74 |
| Formula | C25H50N10O5 |
| Cas No. | 1417302-71-6 |
| Sequence | Leu-Val-Lys-Gly-Arg-NH2 |
| Sequence Short | LVKGR-NH2 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 250 mg/mL (438.03 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (5.78 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.